Bag Shares of RETA Cheaper Than the CFO Did
January 21, 2022 at 13:47 PM EST
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on December 31, Reata Pharmaceuticals Inc's CFO, Manmeet Singh Soni, invested $419,564.80 into 16,000 shares of RETA, for a cost per share of $26.22..